시드니, March 26, 2025 (GLOBE NEWSWIRE) -- 손해보험(P&C) 및 일반 보험의 미래를 만들어가는 글로벌 기업인 Duck Creek Technologies가 사우스 오스트레일리아의 개인대상 최대 보험사인 RAA와 SaaS 핵심 보험 제공 프로세스 기술 관련 신규 파트너십을 체결한다고 발표했다. 온디맨드 방식의 클라우드 제공 플랫폼을 통해 제공되는 보험 정책과 평가, 청구, 클레임 및 명확성(데이터 및 인사이트)을 포함한 …
SYDNEY, March 26, 2025 (GLOBE NEWSWIRE) -- Duck Creek Technologies, penyedia global yang mentakrifkan masa depan insurans harta benda dan kemalangan (P&C) serta insurans am, telah mengumumkan kerjasama baharu dalam teknologi penghantaran insurans teras …
ซิดนีย์, March 26, 2025 (GLOBE NEWSWIRE) -- Duck Creek Technologies ผู้ให้บริการโซลูชันระดับโลกที่กำหนดอนาคตของทรัพย์สินและอุบัติเหตุ (P&C) และการประกันภัยทั่วไป ได้ประกาศความร่วมมือด้านเทคโนโลยีการให้บริการประกันภัยหลักแบบ SaaS ใหม่กับ RAA …
悉尼, March 26, 2025 (GLOBE NEWSWIRE) -- 引領財產與意外險 (P&C) 及一般保險未來的全球供應商 Duck Creek Technologies，宣布與南澳最大的個人險保險公司 RAA 建立全新的 SaaS 核心保險交付技術合作關係。 Duck Creek 透過其 OnDemand 雲端交付平台提供的解決方案——包括政策、評級、帳單、索賠和清晰度（數據和見解），將取代 RAA 在個人、汽車和家居保險產品方面現有的本地舊版技術。 Duck Creek …
シドニー発, March 26, 2025 (GLOBE NEWSWIRE) -- 損害保険および一般保険の未来を定義するグローバルプロバイダーであるダック・クリーク・テクノロジーズは、南オーストラリア州最大の個人向け保険会社であるRAAとのSaaSコア保険配信テクノロジーに関する新たな提携を発表した。 オンデマンド (OnDemand) クラウド配信プラットフォームを介して提供されている、ポリシー (Policy)、 レーティング (Rating)、ビリング (Billing)、クレイムズ (Claims …
悉尼, March 26, 2025 (GLOBE NEWSWIRE) -- Duck Creek Technologies，作为定义财产与意外险 (P&C) 和一般保险未来的全球供应商，宣布与南澳大利亚最大的个人业务保险公司 RAA 建立新的 SaaS 核心保险交付技术合作伙伴关系。 Duck Creek 解决方案，包括保单管理、费率计算、账单管理、理赔和 Clarity（数据和洞察），通过其 OnDemand 云交付平台实施，将取代 RAA 现有的本地部署传统技术，用于其个人汽车和家庭保险产品。 …
The app enables players, parents, and coaches to track at bats accelerating their development curve BOSTON, MA, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- Pelotero today unveiled Plate Intelligence, the latest enhancement to its market …
FINTRX and Intapp partner to provide comprehensive data and insights on firms and contacts directly within their processes and workflows in DealCloud Intapp (NASDAQ:INTA) BOSTON, MA, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- FINTRX, …
Erik Nicolaisen and Chuck Slavin Urge Swift Action on AI/GAI Disclosure Resolution After Strong Support at SAG-AFTRA National Convention BOSTON, MA, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- Erik Nicolaisen and Chuck Slavin Urge …
CAMBRIDGE , MA, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- Gleamer, a leading innovator in artificial intelligence-powered medical imaging solutions, announced today that its advanced chest X-ray interpretation solution, ChestView, has …
Innovative solution secures multimodal AI systems from emerging security, bias, and compliance risks BOSTON, MA, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- Enkrypt AI, a leader in AI security and compliance – is proud to announce the …
Company Prepares to Scale Business with Proprietary Microscale Magnetic Resonance Technology BOSTON, MA, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- LarmorBio, a Massachusetts Institute of Technology (MIT) start-up pioneering the use of …
Company Signs MoU (Memorandum of Understanding) and Joins Elite Group Representing 78% of Global Mobile Connections BOSTON, MA, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- netnumber is proud to announce it has signed an MoU to support …
SYDNEY, March 25, 2025 (GLOBE NEWSWIRE) -- Duck Creek Technologies, the global provider defining the future of property and casualty (P&C) and general insurance, has announced a new SaaS core insurance delivery technology partnership with South …
BOSTON, March 25, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that three abstracts …
- FHD-909 (LY4050784) advancing in an ongoing Phase 1 trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population - Oral presentation on preclinical data for FHD-909 in combination with chemotherapy, …
WATERTOWN, Mass. and GOSSELIES, Belgium, March 25, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for …
WALTHAM, Mass. and BOULDER, Colo., March 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced four preclinical poster …
WOBURN, Mass., March 25, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq:ABP) ("Abpro"), a biotechnology company dedicated to advancing next-generation antibody therapies for severe and life-threatening diseases, today announced an oral …
BOSTON, March 25, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that five abstracts have …
